ArticleMolecular cancer therapeutics2020

PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.

James T Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.